TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

Objective: to study the time course of changes in laboratory biomarkers in patients with rheumatoid arthritis (RA) 2, 4, and 8 weeks after the initiation of tocilizumab (TCZ) therapy. Subjects and methods. Forty-two RA patients receiving two intravenous infusions of TCZ (8 mg/kg each) at a 4-week in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: E N Aleksandrova, E Yu Panasyuk, A S Avdeyeva, A A Novikov, G V Lukina, M V Cherkasova, N V Klimova, E L Nasonov
Materyal Türü: Artigo
Dil:Russo
Baskı/Yayın Bilgisi: IMA-PRESS LLC 2011-06-01
Seri Bilgileri:Научно-практическая ревматология
Konular:
rheumatoid arthritis, interleukin-6
interleukin-6 receptors
tocilizumab, erythrocyte sedimentation rate
c-reactive protein, igm/iga rheumatoid factor
anti-cyclic citrullinated peptide antibodies
anti-modified citrullinated vimentin antibodies
Online Erişim:https://rsp.mediar-press.net/rsp/article/view/705
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller